Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 4/20 | 0.57 |
| ▸ | GLO1 | Q04760 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | ALPL | P05186 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | ALPG | P10696 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | MMP14 | P50281 | 1/20 | 0.56 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.56 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28117263 | 0.86 | MPL (0.67) | GLO1MAPTKMT2AMEN1TDP1 | |
| SCHEMBL29624560 | 0.86 | THRB (0.61) | GLO1MAPTKMT2AMEN1TDP1 | |
| SCHEMBL10723393 | 0.86 | GLO1 (0.79) | GLO1MAPTKMT2AMEN1TDP1 | |
| SCHEMBL29423647 | 0.85 | THRB (0.64) | GLO1MAPTKMT2AMEN1TDP1 | |
| SCHEMBL136632 | 0.85 | THRB (0.64) | GLO1MAPTKMT2AMEN1TDP1 | |
| SCHEMBL29394555 | 0.83 | GLO1 (0.68) | GLO1MAPTKMT2AMEN1TDP1 | |
| SCHEMBL29378285 | 0.83 | MAPT (0.78) | GLO1MAPTKMT2AMEN1TDP1 | |
| SCHEMBL29353711 | 0.83 | MAPT (0.78) | GLO1MAPTKMT2AMEN1TDP1 | |
| SCHEMBL339399 | 0.83 | MAPT (0.78) | GLO1MAPTKMT2AMEN1TDP1 | |
| SCHEMBL144504 | 0.83 | MAPT (0.78) | GLO1MAPTKMT2AMEN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250025426-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2025-01-23 | — | — | US | claimed |
| EP-4444275-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2024-10-16 | — | — | EP | claimed |
| WO-2023104380-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2023-06-15 | — | — | WO | claimed |
| EP-4190312-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE AGENTS INTO NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2023-06-07 | — | — | EP | claimed |
| US-20220403193-A1 | AQUEOUS INK COMPOSITION, INK SET, PRINTED MATERIAL, AND METHOD OF PRODUCING PRINTED MATERIAL | DIC CORPORATION (JP) | 2022-12-22 | — | — | US | claimed |
| EP-4067085-A1 | AQUEOUS INK COMPOSITION, INKSET, PRINTED MATTER, AND METHOD FOR MANUFACTURING PRINTED MATTER | DIC Corporation (JP) | 2022-10-05 | — | — | EP | claimed |
| CN-114641543-A | Aqueous ink composition, ink set, printed matter, and method for producing printed matter | DIC株式会社 | 2022-06-17 | — | — | CN | claimed |
| CN-111004414-B | Two-component intercalated hydrotalcite-like additive and application thereof in polypropylene plastics | 北京林业大学 | 2022-05-03 | — | — | CN | claimed |
| EP-3980140-A2 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | FRS Group, LLC (US) | 2022-04-13 | — | — | EP | claimed |
| US-12629555-B2 | Long-term fire retardant with magnesium sulfate and corrosion inhibitors and methods for making and using same | PERIMETER SOLUTIONS, LP (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4731312-A1 | SYSTEMS, APPARATUS, AND METHODS FOR DILUTION AND EFFECTIVE MIXING OF HIGH VISCOSITY LONG-TERM FIRE RETARDANT LIQUID CONCENTRATES | Perimeter Solutions LP (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-3434764-B1 | FABRIC AND HOME CARE PRODUCTS | PROCTER & GAMBLE (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260014404-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | PERIMETER SOLUTIONS, LP (US) | 2026-01-15 | — | — | US | disclosed |
| WO-2025264733-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | PERIMETER SOLUTIONS, LP (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-3980140-A2 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | FRS Group, LLC (US) | 2022-04-13 | — | — | EP | disclosed |
| CN-114206302-A | Process for dyeing keratin materials comprising the use of an organosilicon compound, a coated effect pigment and a film-forming polymer II | 汉高股份有限及两合公司 | 2022-03-18 | — | — | CN | disclosed |
| US-20220080242-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2022-03-17 | — | — | US | disclosed |
| US-20220072355-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2022-03-10 | — | — | US | disclosed |
| EP-3964554-A1 | COMPOSITON SENSITIVE TO UV-C RADIATION AND UV-C STERILIZATION OR DISINFECTION DOSIMETER | Terragene LLC (US) | 2022-03-09 | — | — | EP | disclosed |
| WO-2022034498-A1 | MOVING-FRONT STERILIZATION MONITORING DEVICES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629555-B2 | Long-term fire retardant with magnesium sulfate and corrosion inhibitors and methods for making and using same | SLC6A12, SLC9A2, SLC11A2 | THRB 1787/4885GLO1 1878/4885MAPT 301/4885 |
| US-20260014404-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | SLC6A12, SLC11A2, KCNN1 | THRB 1011/4885GLO1 4215/4885MAPT 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.